Product Information
AMLODIPINE-VALSARTAN-HYDROCHLOROTHIAZIDE 5-160-25 MG TAB is a generic product labeled by Strides Pharma Inc., priced at $4.2386 per EA under NDC 64380019801. Its NADAC has been published 129 times since Apr 17, 2024.
FDA first approved this application on Jun 1, 2015. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
AMLODIPINE-VALSARTAN-HYDROCHLOROTHIAZIDE 5-160-25 MG TAB
amlodipine besylate valsartan hydrochlorothiazideStrength
5; 25; 160 mg/1; mg/1; mg/1
Manufacturer
Strides Pharma Inc.NDC
64380019801
Classification
Generic
Dosage Form
TABLET, FILM COATED
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
AMLODIPINE BESYLATE; HYDROCHLOROTHIAZIDE; VALSARTANApproval Type
Generic (ANDA)
FDA Application
ANDA201087FDA Approved
6/1/2015
TE Code
AB
On Market Since
6/27/2022
Pharmacological Classes
Price Statistics
The NADAC for AMLODIPINE-VALSARTAN-HYDROCHLOROTHIAZIDE 5-160-25 MG TAB has been published 129 times since Apr 17, 2024, and over the history we have for it it has declined 42.8%. The table below summarizes its recorded NADAC range and movement.
| Current price | $4.2386 per EA |
|---|---|
| All-time high | $7.4082 (May 15, 2024) |
| All-time low | $4.2386 (Sep 23, 2026) |
| 52-week high | $7.2659 |
| 52-week low | $4.2386 |
| Median price | $6.7819 |
| Average price | $6.5083 |
| Largest weekly change | -7.2% (Jul 22, 2026) |
| Weeks tracked | 129 |
| Tracking since | Apr 17, 2024 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the amlodipine besylate valsartan hydrochlorothiazide market page.
Lowest-Cost Alternatives
No alternatives available
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Strides Pharma Inc. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
amlodipine besylate valsartan hydrochlorothiazide market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Angiotensin 2 Receptor Blocker class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of AMLODIPINE-VALSARTAN-HYDROCHLOROTHIAZIDE 5-160-25 MG TAB?
The current National Average Drug Acquisition Cost (NADAC) for AMLODIPINE-VALSARTAN-HYDROCHLOROTHIAZIDE 5-160-25 MG TAB, manufactured by Strides Pharma Inc., is $4.2386 per EA (NDC 64380019801), effective Sep 30, 2026.
How has the price of AMLODIPINE-VALSARTAN-HYDROCHLOROTHIAZIDE 5-160-25 MG TAB changed over time?
Over the history we have for it, the NADAC for AMLODIPINE-VALSARTAN-HYDROCHLOROTHIAZIDE 5-160-25 MG TAB has declined 42.8%. It has been tracked across 129 weekly CMS publications since Apr 17, 2024.
What are the highest and lowest recorded NADAC prices for AMLODIPINE-VALSARTAN-HYDROCHLOROTHIAZIDE 5-160-25 MG TAB?
Since Apr 17, 2024, the NADAC for AMLODIPINE-VALSARTAN-HYDROCHLOROTHIAZIDE 5-160-25 MG TAB has ranged from a low of $4.2386 (Sep 23, 2026) to a high of $7.4082 (May 15, 2024), with a median of $6.7819 per EA.
Are there cheaper alternatives to AMLODIPINE-VALSARTAN-HYDROCHLOROTHIAZIDE 5-160-25 MG TAB?
No other NADAC-published product currently shares the active ingredient and strength of AMLODIPINE-VALSARTAN-HYDROCHLOROTHIAZIDE 5-160-25 MG TAB in a comparable dosage form, so no direct lower-cost alternative is listed.
Who manufactures AMLODIPINE-VALSARTAN-HYDROCHLOROTHIAZIDE 5-160-25 MG TAB?
AMLODIPINE-VALSARTAN-HYDROCHLOROTHIAZIDE 5-160-25 MG TAB (NDC 64380019801) is labeled by Strides Pharma Inc., and CMS classifies it as a generic product.